Biomea Fusion BMEA
NASDAQ BMEA
$0.71 -0.02 (-3.33%)
As of: Oct 21, 2026 · 1:00 PM EDT

Biomea Fusion (BMEA) Preferred Stock Liabilities (2020 - 2021)

Updated

Biomea Fusion (BMEA) recorded Preferred Stock Liabilities of $55.74 million in Q1 2021, unchanged from the prior quarter.

Analysis

Biomea Fusion (BMEA) Preferred Stock Liabilities (2020 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,134.62 Bn 1,103.20 Bn 19.71 Bn -
2 Johnson & Johnson 616.94 Bn 535.47 Bn 17.26 Bn -
3 AbbVie 501.32 Bn 474.43 Bn 12.70 Bn -
4 Merck 367.44 Bn 321.82 Bn 12.21 Bn -
5 Novartis Ag 298.20 Bn 262.19 Bn 11.24 Bn -
6 Astrazeneca 261.78 Bn 235.47 Bn 12.86 Bn -
7 Amgen 235.70 Bn 191.10 Bn 7.24 Bn -
8 Gilead Sciences 190.88 Bn 165.07 Bn 6.22 Bn -
9 Pfizer 169.72 Bn 116.36 Bn 10.94 Bn -
10 Biomea Fusion 51.46 Mn -130.88 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 55.74 Mn
Dec 31, 2020 55.74 Mn
API Access

Biomea Fusion Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=BMEA&period=max&api_key=YOUR_API_KEY